We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

Wuxi Biologics (Cayman) Inc. announced a significant asset transaction involving its Vaccines Ireland Facility, selling it to MSD International for approximately US$500 million. The transaction ...

WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

We've identified the following companies as similar to WuXi Biologics (Cayman) Inc. because they operate in a related industry or sector. We also considered size, growth, and various financial ...

1 Day WXIBF 2.68% DJIA 0.92% S&P 500 0.53% Health Care/Life Sciences 0.09% ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

We've identified the following companies as similar to WuXi Biologics (Cayman) Inc. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics ...